Aeolus Pharmaceuticl Stock Probability of Future Pink Sheet Price Finishing Over 2.0E-4

AOLS Stock  USD 0.0002  0.0001  100.00%   
Aeolus Pharmaceuticl's future price is the expected price of Aeolus Pharmaceuticl instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Aeolus Pharmaceuticl performance during a given time horizon utilizing its historical volatility. Check out Aeolus Pharmaceuticl Backtesting, Aeolus Pharmaceuticl Valuation, Aeolus Pharmaceuticl Correlation, Aeolus Pharmaceuticl Hype Analysis, Aeolus Pharmaceuticl Volatility, Aeolus Pharmaceuticl History as well as Aeolus Pharmaceuticl Performance.
  
Please specify Aeolus Pharmaceuticl's target price for which you would like Aeolus Pharmaceuticl odds to be computed.

Aeolus Pharmaceuticl Target Price Odds to finish over 2.0E-4

The tendency of Aeolus Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.0002 90 days 0.0002 
near 1
Based on a normal probability distribution, the odds of Aeolus Pharmaceuticl to move above the current price in 90 days from now is near 1 (This Aeolus Pharmaceuticl probability density function shows the probability of Aeolus Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Aeolus Pharmaceuticl has a beta of -1.9. This suggests as returns on its benchmark rise, returns on holding Aeolus Pharmaceuticl are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Aeolus Pharmaceuticl is expected to outperform its benchmark. Moreover Aeolus Pharmaceuticl has an alpha of 1.6983, implying that it can generate a 1.7 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Aeolus Pharmaceuticl Price Density   
       Price  

Predictive Modules for Aeolus Pharmaceuticl

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Aeolus Pharmaceuticl. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.000112.60
Details
Intrinsic
Valuation
LowRealHigh
0.000.000112.60
Details
Naive
Forecast
LowNextHigh
0.0000050.000312.60
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

Aeolus Pharmaceuticl Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Aeolus Pharmaceuticl is not an exception. The market had few large corrections towards the Aeolus Pharmaceuticl's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Aeolus Pharmaceuticl, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Aeolus Pharmaceuticl within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.70
β
Beta against Dow Jones-1.9
σ
Overall volatility
0.000024
Ir
Information ratio 0.11

Aeolus Pharmaceuticl Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Aeolus Pharmaceuticl for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Aeolus Pharmaceuticl can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Aeolus Pharmaceuticl is way too risky over 90 days horizon
Aeolus Pharmaceuticl has some characteristics of a very speculative penny stock
Aeolus Pharmaceuticl appears to be risky and price may revert if volatility continues
Aeolus Pharmaceuticl has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 2.08 M. Net Loss for the year was (3.56 M) with loss before overhead, payroll, taxes, and interest of (805 K).
Aeolus Pharmaceuticl currently holds about 403 K in cash with (3.11 M) of positive cash flow from operations.

Aeolus Pharmaceuticl Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Aeolus Pink Sheet often depends not only on the future outlook of the current and potential Aeolus Pharmaceuticl's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aeolus Pharmaceuticl's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding152.1 M
Cash And Short Term Investments3.2 M

Aeolus Pharmaceuticl Technical Analysis

Aeolus Pharmaceuticl's future price can be derived by breaking down and analyzing its technical indicators over time. Aeolus Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Aeolus Pharmaceuticl. In general, you should focus on analyzing Aeolus Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Aeolus Pharmaceuticl Predictive Forecast Models

Aeolus Pharmaceuticl's time-series forecasting models is one of many Aeolus Pharmaceuticl's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Aeolus Pharmaceuticl's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Aeolus Pharmaceuticl

Checking the ongoing alerts about Aeolus Pharmaceuticl for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Aeolus Pharmaceuticl help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Aeolus Pharmaceuticl is way too risky over 90 days horizon
Aeolus Pharmaceuticl has some characteristics of a very speculative penny stock
Aeolus Pharmaceuticl appears to be risky and price may revert if volatility continues
Aeolus Pharmaceuticl has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 2.08 M. Net Loss for the year was (3.56 M) with loss before overhead, payroll, taxes, and interest of (805 K).
Aeolus Pharmaceuticl currently holds about 403 K in cash with (3.11 M) of positive cash flow from operations.

Additional Tools for Aeolus Pink Sheet Analysis

When running Aeolus Pharmaceuticl's price analysis, check to measure Aeolus Pharmaceuticl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aeolus Pharmaceuticl is operating at the current time. Most of Aeolus Pharmaceuticl's value examination focuses on studying past and present price action to predict the probability of Aeolus Pharmaceuticl's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aeolus Pharmaceuticl's price. Additionally, you may evaluate how the addition of Aeolus Pharmaceuticl to your portfolios can decrease your overall portfolio volatility.